#Germany #Berlin #Ozelle #EHBT-50 #German Innovation Awards

Ozelle Triumphs at the German Innovation Awards

In a significant achievement for the healthcare technology sector, Ozelle has been awarded the prestigious Gold Award at the German Innovation Awards. This accolade, one of the most esteemed recognitions in the country, highlights the company's commitment to enhancing medical diagnostics through cutting-edge technology. The award was bestowed upon Ozelle's multifunctional EHBT-50 Mini Lab analyzer, which represents a major leap in hematological analysis.

The German Innovation Awards celebrate products and technologies that deliver substantial value to users while upholding engineering excellence and real-world impact. Ozelle's EHBT-50 Mini Lab was commended particularly in the Medical Technologies category, emphasizing its ability to meet the pressing demand for faster, more accessible diagnostic solutions outside traditional laboratory settings.

Innovation in Clinical Settings

The EHBT-50 is engineered specifically for decentralized clinical environments, seamlessly integrating hematology analysis, biochemistry, immunoassays, and morphological analysis with artificial intelligence into one advanced diagnostic platform. With diagnostic testing on the rise in frontline healthcare environments, laboratories are under increasing pressure due to staffing shortages, complex workflows, and delayed turnaround times. In many decentralized healthcare settings, the advanced morphological analysis still heavily relies on specialized personnel and centralized laboratory infrastructure. Ozelle's aim is to streamline these workflows while maintaining laboratory-level analytical capabilities in everyday clinical practice.

Promoting the adoption of advanced laboratory analysis, the EHBT-50 incorporates Ozelle's AI × CBM (Complete Blood Morphology) technology. This innovation facilitates standardized morphological analysis and rapid identification of abnormal cells, significantly reducing the reliance on highly specialized manual reviews in routine analytical environments. By combining AI-assisted interpretation with consistent cellular imaging, Ozelle ensures increased accuracy and reliability across various clinical settings.

For everyday clinical use, the EHBT-50 features a maintenance-free architecture, all-in-one sealed cartridges, room temperature reagents, and simplified one-click testing protocols designed to alleviate operational complexity. The system also supports flexible analysis panels for applications such as infection assessment, diabetes control, and thyroid testing, thus empowering healthcare providers to manage a broader scope of diagnostic needs without dependence on multiple standalone analyzers.

Founded in Silicon Valley in 2014, Ozelle has rapidly expanded its global operations, including a significant presence in Frankfurt, where it develops AI and IoT-based diagnostic systems for both medical and veterinary applications. In response to receiving the Gold Award, Ozelle stated, "This recognition highlights the growing interest in diagnostic systems that can reliably operate in real-world clinical environments. We believe that hematology is entering a new era where AI and morphological intelligence are increasingly integrated into routine clinical workflows.”

Ozelle invites healthcare professionals to request a live demonstration of its AI-driven diagnostic solutions, showcasing their commitment to revolutionizing the landscape of medical diagnostics in real-time hospital and clinic settings. For more information, visit www.ozellemed.com or contact them directly via email at [email protected].